Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
215 3 |
Ultima descărcare din IBN: 2023-07-03 23:55 |
Căutarea după subiecte similare conform CZU |
616.9:578.834.1-036-08 (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585) |
Virologie (442) |
SM ISO690:2012 CÎVÎRJIC, Ivan, BELÎI, Adrian, CRIVORUCICA, Veaceslav, VOLEAC, Ina, STEFANȚOV, Natalia, RUSSU, Galina. Dynamics of Covid-19 patient outcome from institute of emergency medicine as a result of the application of noninvasive ventilation. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 301. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 616.9:578.834.1-036-08 | ||||||
Pag. 301-301 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introduction. COVID-19 is a pandemic infectious disease. The rate of pulmonary manifestation is 33%,and presents a therapeutic and respiratory support challenge. There is a lack of a clear consensus on the results and applicability of various forms of non-invasive ventilation in COVID-19 patients. Aim. To evaluate the results of applying non-invasive ventilation as a form of respiratory support to patients with COVID-19 disease. Materials and methods. Patients admitted to the ICU of the Institute of Emergency Medicine were evaluated and divided into 2 groups: L1-between 04.04.2020- 30.06.2020 until the introduction of non-invasive ventilation (NIV) in clinical practice and L2-hospitalized between 01.07.2020 and 15.10.202 after the introduction of NIV. Results: 930 patients were included, L1-465 patients, L2-465 patients. Mean age (years) 59.8 (L1) and 61.6 (L2), men 52% (L1) and 52% (L2). NIV ventilation was used in 230 patients in L2 (49.46%) The average ICU length of stay (days) was 7.3 (L1) and 7.74 (L2) (p < 0.014),the average length of hospital stay (days) was 14.74 (L1) and 13.23 (L2) (p < 0.01) and duration of mechanical ventilation (MV) (days) 5.23 - (L1) and 5.38 (L2) (p < 0.14). The duration of the ICU stay in NIV patients – 9.59 days, the duration of hospitalization 14.9 days, the NIV failure rate 47% and the duration of MV in case of failure 5.7 days. Mortality was 46% (L1) and 57% (L2) (p <0.05). Mortality in patients NIV 42%, in those with NIV failure 88% and patients with MV 90%. Conclusions. In the performed analysis, the benefit of non-invasive ventilation was highlighted only on the average duration of hospitalization. Randomizations are required in order to evaluate the benefit of non-invasive ventilation on different severity groups. |
||||||
Cuvinte-cheie non-invasive ventilation, COVID-19, ventilație non-invazivă, COVID-19 |
||||||
|